ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...
Главные авторы: | Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
BMJ Publishing Group
2016
|
Схожие документы
-
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
по: Craig, SE, и др.
Опубликовано: (2012) -
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
по: Craig, SE, и др.
Опубликовано: (2012) -
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
по: Schulz, U, и др.
Опубликовано: (2013) -
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
по: Bratton, D, и др.
Опубликовано: (2014) -
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
по: Ayers, L, и др.
Опубликовано: (2009)